3-O-Ethyl-L-ascorbic acid
CAS No. 86404-04-8
3-O-Ethyl-L-ascorbic acid( —— )
Catalog No. M21319 CAS No. 86404-04-8
3-O-Ethyl-L-ascorbic acid is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | 37 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name3-O-Ethyl-L-ascorbic acid
-
NoteResearch use only, not for human use.
-
Brief Description3-O-Ethyl-L-ascorbic acid is a chemical compound.
-
Description3-O-Ethyl-L-ascorbic acid is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number86404-04-8
-
Formula Weight204.18
-
Molecular FormulaC8H12O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (489.76 mM)
-
SMILESCCOC([C@@H]([C@H](CO)O)OC1=O)=C1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Victoria-Martínez Ana M Mercader-García Pedro. Allergic Contact Dermatitis to 3-o-Ethyl-L-Ascorbic Acid in Skin-lightening Cosmetics[J]. Dermatitis 2017 28(1):89.
molnova catalog
related products
-
DO1
DO1 is an anti-amyloid agent which potently delays both seeded and non-seeded Aβ42 polymerization at substoichiometric concentrations.
-
Letolizumab
Letolizumab (BMS-986004) is a dimeric antibody targeting CD40L for the expression of mutant IgG1 that lacks effector functions including Fc binding and complement binding.
-
Aloveroside A
Aloveroside A is a triglucosylnaphthalene derivative isolated from ethanolic extract of aloe vera. Aloveroside A has weak bACE inhibitory activity (inhibition rate at a dose of 100 μg/mL is approximately 18.68%).
Cart
sales@molnova.com